Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

(Batesville, IN) – Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital.

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.

The US-based private equity firm and Mitsubishi are finalising details of a transaction that could be announced as soon as ...

BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, ...

Ken Griffin’s hedge fund is taking a fraction of the space in its exit from Citadel Center; TPG Angelo Gordon negotiating ...

Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.

Tower Capital’s LA office is a base for its new retail-focused capital markets group, which will line up capital for clients ...